GSK posted higher profit as sales for its specialty treatments for HIV, cancer and asthma beat expectations, offsetting lower ...

Gilead Sciences agreed to pay $202 million to settle a whistleblower lawsuit accusing the drugmaker of civil fraud for paying ...

A New York doctor who treated HIV and AIDS patients sued Gilead for violating the False Claims Act with payments to doctors ...

A panelist discusses how the HIV patient population has aged significantly, with the average age in their clinic now ...

In Zambia, truck drivers and sex workers have high rates of being HIV positive —- and are at high risk of contracting the ...

An ambitious plan to stop the global threat of AIDS has been derailed. But many are hopeful that progress can be salvaged.

Among programs slated for elimination are ones disproportionately impacting LBGTQ people, including HIV prevention and ...

The US administration should clear up the confusion over the future of a widely admired AIDS fund and push for Congress to ...

Cuts to sexual health clinics could make eliminating new HIV cases in England by 2030 “impossible”, politicians have warned.

Dolutegravir is recommended by the World Health Organization (WHO) for infants, children and adults and is the preferred HIV ...

The Uganda AIDS Commission (UAC) has reported a continued decline in new HIV infections, though the country still falls short ...

An HIV patient in Laredo is sharing his advice with others living with the disease to raise awareness and highlight available ...